Quantcast

Latest Atheroma Stories

2011-06-03 13:17:57

Immune cells secrete a signal molecule that promotes atherosclerosis In Western societies, atherosclerosis of the arteries is one of the leading causes of death. Chronic, localized inflammation of the blood vessel wall facilitates the growth of fibrous plaques, which leads to narrowing or occlusion of the vessel, and thereby promotes heart attacks and stroke. The persistence of the inflammatory reaction is due to a loss of control over the activity of the immune system. So-called dendritic...

2011-05-17 13:13:28

The coronary arteries of Princess Ahmose-Meryet-Amon -- visualized by whole body computerized tomography scanning The coronary arteries of Princess Ahmose-Meryet-Amon - as visualised by whole body computerised tomography (CT) scanning - will feature in two presentations at the International Conference of Non-Invasive Cardiovascular Imaging (ICNC) this week in Amsterdam (15-18 May). ICNC is now one of the world's major scientific event in nuclear cardiology and cardiac CT imaging. The Egyptian...

2011-05-06 10:37:00

ABBOTT PARK, Ill., May 6, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) approved the RX ACCULINK® Carotid Stent System for the treatment of patients with carotid artery disease who are at standard risk of adverse events from carotid endarterectomy (surgery). RX ACCULINK was previously indicated for patients at high risk of adverse events from surgery. This expanded indication is supported by the results of the...

2011-04-28 12:04:00

HOUSTON, April 28, 2011 /PRNewswire/ -- SpectraCell Laboratories has officially been granted a license to provide its Lipoprotein Particle Profile(TM) (LPP(TM)) test, which assesses cardiovascular risk, to New York state physicians and patients. The recently patented LPP(TM) test has been commercially available to the other 49 states since 2006. SpectraCell began the process of acquiring a licensure in 2008 with an application submission to the state of New York. The laboratory...

2011-03-24 13:09:00

New DMC Cardiovascular Institute technique restores blood flow to lower limbs DETROIT, March 24, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation. The innovative new procedure is aimed at greatly reducing the need for lower-limb amputations by restoring interrupted blood-flow to...

2011-03-07 17:24:13

New method could sensitively detect pre-atherosclerotic regions that otherwise showed no clinical signs of atherosclerosis A new study published in the Annals of Biomedical Engineering shows that a MEMS thermal sensor deployed by an angiogram catheter can detect the earliest stages of atherosclerosis. The MEMS thermal sensor used convective heat transfer to detect pre-atherosclerotic regions of arteries that otherwise showed no clinical signs of atherosclerosis. Although diet and lifestyle...

2011-02-09 00:01:31

SHAPE today urged journalists working on American Heart Month stories to update their advice for how apparently healthy individuals can discover hidden heart attack risk. SHAPE encourages physicians to implement screening for subclinical (asymptomatic) atherosclerosis (cholesterol plaque build-up) in men age 45 and older, and women age 55 and older who are at risk for atherosclerotic cardiovascular disease. SHAPE recommends two scientifically proven non-invasive atherosclerosis tests:...

0d6ccd1fa768d45388248b8958cdfd0c
2011-02-03 12:28:00

For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks.Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology.According to Gregory Lanza, MD, PhD, a Washington University cardiologist at Barnes-Jewish Hospital, these nanoparticles will take the guesswork out of deciding whether a person coming...

2011-01-20 15:22:42

PROSPECT trial published in New England Journal of Medicine Results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur. The trial, Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT), is the first prospective natural history study of atherosclerosis using multi-modality...

2011-01-13 14:04:43

Discovery could influence development of new HDL-targeted therapies The discovery that high levels of high-density lipoprotein (HDL) cholesterol (the "good cholesterol") is associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain. However, recent findings have called into question the notion that pharmacologic increases in HDL cholesterol levels are necessarily beneficial to patients. Now, a new study from researchers at...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.